Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
Eli Lilly and Company logo — Discovery, development, manufacture, and sale of products in...

Eli Lilly and Company

Discovery, development, manufacture, and sale of products in pharmaceutical products business segment

Founded 1876 United States Indianapolis, United States 57114 employees IPO Total: $13.31B Biotechnology, Health Care +1

General Information

Company Name Eli Lilly and Company
Founded Year 1876
Location United States Indianapolis, United States +1
Employees 57114
Industries Biotechnology, Health Care, Pharmaceutical
Funding Stage IPO
Social

Get notified when Eli Lilly and Company moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About Eli Lilly and Company

Eli Lilly and Company, founded in 1876, is a pioneering entity in the Biotechnology, Health Care, and Pharmaceutical industries. With a focus on turning science into healing, the company has consistently devoted efforts to advance biotechnology, chemistry, and genetic medicine. Their commitment aligns with their founder’s vision to perpetually improve what has been established.

Headquartered in the United States, Eli Lilly channels its scientific endeavors toward solving major global health challenges. As of 01 April 2026, the company received a Post IPO Equity investment, which highlights its continual growth and investor confidence in the financial sector.

This strategic infusion will serve as a cornerstone for Eli Lilly in its unyielding pursuit to enhance pharmaceutical solutions globally, maintaining its century-spanning legacy of innovation.

Taxonomy: Pharmaceutical Development, Genetic Medicine, Chemistry, Biopharmaceuticals, Medicine Manufacturing, Animal Health, Healthcare Innovation, Global Distribution, Scientific Research, Health Challenges Solutions, Drug Discovery, Therapeutics, Life Sciences, Animal Food Production Efficiency

Services & Products

Medicine Manufacturing
Patient Care Services
Clinical Trials Management
Pharmacy Access

Target Customers

Patients with Chronic Conditions Healthcare Professionals Individuals Seeking Medical Information Participants for Clinical Trials

Funding Rounds & Investors (5)

View All
Funding Stage Amount Investors Lead Investors Date
Post Ipo Equity •••••• 1
Investor
01 Apr 2026
Post Ipo Equity •••••• - 01 Dec 2025
Post Ipo Debt •••••• - 01 Feb 2025
Post Ipo Debt •••••• - 01 Feb 2024
Grant •••••• 1 •••• •••• 01 Dec 2020

Latest News

View All
Eli Lilly, Juvena Therapeutics Partner to Develop Muscle-Boosting Drugs Using AI Platform — Finance.yahoo.com
Eli Lilly, Juvena Therapeutics Partner to Develop Muscle-Boosting Drugs Using AI Platform
Finance.yahoo.com Jun 16, 2025
Alentis Appoints Mark Pruzanski as CEO — Biospace.com
Alentis Appoints Mark Pruzanski as CEO
Biospace.com Oct 16, 2025

Eli Lilly and Company Alternatives & Competitors

View All Alternatives
Eli Lilly and Company vs
GIGI VET
GIGI VET Latvia

GIGI VET manufactures and distributes veterinary medicine and nutritional supplement products.

6 employees
Health and Wellness, Manufacturing
Compare Eli Lilly and Company vs GIGI VET
Eli Lilly and Company vs
Daiichi Sankyo US
Daiichi Sankyo US United States

We create life-changing solutions for patients.

4116 employees
Health Care, Health and Wellness
Compare Eli Lilly and Company vs Daiichi Sankyo US
Eli Lilly and Company vs
Ayush Herbs, Inc.
Ayush Herbs, Inc. United States

Doctor-Formulated Ayurvedic Herbal Products.

119 employees
Also compare with: Eli Lilly and Company vs Prevail Therapeutics Prevail Therapeutics View all alternatives

FAQ About Eli Lilly and Company

Discovery, development, manufacture, and sale of products in pharmaceutical products business segment
Eli Lilly and Company was founded in 1876.
Eli Lilly and Company is headquartered in Indianapolis, United States.
Eli Lilly and Company operates in the following industries: Biotechnology, Health Care, Pharmaceutical.
Eli Lilly and Company has approximately 57114 employees.
Eli Lilly and Company has completed 5 funding rounds, raising a total of $13.31B. The latest funding stage is IPO.
Eli Lilly and Company offers: Medicine Manufacturing, Patient Care Services, Clinical Trials Management, Pharmacy Access.
Top alternatives and competitors to Eli Lilly and Company include GIGI VET, Daiichi Sankyo US, Ayush Herbs, Inc., Prevail Therapeutics, Ferring Pharmaceuticals. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Eli Lilly and Company and GIGI VET are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Eli Lilly and Company and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

See how it works

One analytics cookie (Google Analytics). Cookie Policy

Book a demo 30 minutes